Our portfolio

Noordzee Helikopters Vlaanderen, NHV Group, based in Oostende, Belgium, is specialized in B-to-B aviation services and operates 15 helicopters bases on 2 continents with a staff of more than 600 people. NHV provides services to the Oil & Gas Industry, Harbor Pilots, Wind Farm Operators, Governments, Hospitals and others. International expansion forms the heart of the company's growth strategy, which will be supported by ongoing investment, notably in the extension and the constant rejuvenation of the fleet.

The Sword Group is an international sostware, consulting and service company. They assist world leaders in their technological and digital transformation programs. Created in November 2000, the group now has more than 2,200 employees operating in more than 50 countries. They offer their clients solutions adapted to their activity and strategy.

CLS, a subsidiary of CNES (French Space Agency), Ifremer (French Research Institute for exploration of the sea) and several French financial institutions, offers satellite services in location, environmental data collection, ocean observations, earth location and monitoring, to a broad range of sectors including: government, industry and the scientific community. Ardian will work alongside CLS to strengthen the resources of the group and continue its internal and external expansion.

Acino is a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Ardian alongside Nordic Capital and Avista Capital will support the Group to leverage on the existing emerging markets platform to develop the B2C business through organic and external growth.

Laboratoires Anios is present in more than 80 countries with different business units addressing notably the healthcare segment, through hospitals, clinics, and healthcare professionals. Laboratoires Anios is also present in food-processing, cosmetics, and pharmaceutics industries, as well as in the communities linked to accommodation and catering. International build up acquisitions will form the heart of the company’s growth strategy, which will be supported by ongoing investment, notably in R&D.

SynerLAB is one of the leading French Contract Manufacturing Organisations of generic and ethical pharmaceutical products (i.e. patent protected and prescription sales) supplying laboratories. SynerLAB focuses on dry pharmaceutical forms including capsules, tablets, powders, granules etc and liquid forms such as syrups and mixtures.